Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Purple Biotech Ltd PPBT

Full chart Compare
Set alert

Price alert · PPBT

All alert types
1.25 USD +0.03 (+2.88%)

At closeNov 6, 2026, 4:00 AM EST

1.19 -0.06 -4.80%

Pre-market · Nov 6, 4:00 AM ET

1.16 Day range 1.34
0.91 52-week range 8.90
YTD
-81.00%
1 year
-83.13%

Financial health

Altman Z-Score

-22.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-3 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -1.2×
FY 2016: -14.7×FY 2017: -17.7×FY 2018: -17.8×FY 2019: -27.8×FY 2020: -15.2×FY 2021: -38.9×FY 2022: -11.5×FY 2023: -8.7×FY 2024: -10.6×FY 2025: -1.2×
FY 2016 5y median -10.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 2156×FY 2018: 93.8×FY 2019: 165×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.2×
FY 2016: 13.4×FY 2017: 29.5×FY 2018: 8.9×FY 2019: 15.8×FY 2020: 5.4×FY 2021: 10.9×FY 2022: 5.3×FY 2023: 5.0×FY 2024: 2.3×FY 2025: 3.2×
FY 2016 5y median 5.0× FY 2025
P/FCF -5.7×
FY 2016: -28.5×FY 2017: -25.0×FY 2018: -11.0×FY 2019: -29.4×FY 2020: -35.0×FY 2021: -46.1×FY 2022: -14.7×FY 2023: -8.7×FY 2024: -5.4×FY 2025: -5.7×
FY 2016 5y median -8.7× FY 2025
EV/EBITDA -0.9×
FY 2016: -24.5×FY 2017: -16.4×FY 2018: -16.0×FY 2019: -26.2×FY 2020: -31.9×FY 2021: -39.8×FY 2022: -10.9×FY 2023: -8.0×FY 2024: -9.9×FY 2025: -0.9×
FY 2016 5y median -9.9× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 2116×FY 2018: 88.6×FY 2019: 160×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -17.6%
FY 2016: -3.5%FY 2017: -4.0%FY 2018: -9.1%FY 2019: -3.4%FY 2020: -2.9%FY 2021: -2.2%FY 2022: -6.8%FY 2023: -11.5%FY 2024: -18.7%FY 2025: -17.6%
FY 2016 5y median -11.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -11966.0%FY 2018: -782.6%FY 2019: -715.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -12177.0%FY 2018: -520.0%FY 2019: -585.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -271.6%
FY 2016: -90.6%FY 2017: -166.5%FY 2018: -49.4%FY 2019: -56.1%FY 2020: -35.5%FY 2021: -28.4%FY 2022: -46.2%FY 2023: -58.1%FY 2024: -22.0%FY 2025: -271.6%
FY 2016 5y median -46.2% FY 2025
ROIC -272.9%
FY 2016: -52.7%FY 2017: -118.3%FY 2018: -68.6%FY 2019: -62.9%FY 2020: -16.5%FY 2021: -27.1%FY 2022: -47.3%FY 2023: -64.0%FY 2024: -33.1%FY 2025: -272.9%
FY 2016 5y median -47.3% FY 2025
ROA -150.2%
FY 2016: -81.3%FY 2017: -85.9%FY 2018: -35.3%FY 2019: -39.7%FY 2020: -33.6%FY 2021: -26.2%FY 2022: -39.7%FY 2023: -44.9%FY 2024: -19.5%FY 2025: -150.2%
FY 2016 5y median -39.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 900.0%FY 2019: 0.0%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -149.5%
FY 2016: -76.5%FY 2017: -66.6%FY 2018: 34.6%FY 2019: 8.6%FY 2020: -86.3%FY 2021: -34.5%FY 2022: -26.0%FY 2023: 1.5%FY 2024: 50.6%FY 2025: -149.5%
FY 2016 FY 2025
EPS (diluted) -24.4%
FY 2016: 51.7%FY 2017: 38.9%FY 2018: 71.3%FY 2019: 24.3%FY 2020: 10.7%FY 2021: 60.0%FY 2022: -20.0%FY 2023: 25.2%FY 2024: 75.4%FY 2025: -24.4%
FY 2016 FY 2025
Free Cash Flow 61.4%
FY 2016: -89.1%FY 2017: -37.8%FY 2018: 1.7%FY 2019: 34.2%FY 2020: -119.0%FY 2021: -25.5%FY 2022: -10.4%FY 2023: -17.5%FY 2024: 27.9%FY 2025: 61.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 11.7×FY 2017: 2.0×FY 2018: 2.6×FY 2019: 2.3×FY 2020: 19.1×FY 2021: 11.4×FY 2022: 4.7×FY 2023: 1.6×FY 2024: 2.2×FY 2025: 1.3×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.3×
FY 2016: 17.8×FY 2017: 2.0×FY 2018: 2.3×FY 2019: 2.8×FY 2020: 19.1×FY 2021: 11.4×FY 2022: 4.7×FY 2023: 1.6×FY 2024: 2.2×FY 2025: 1.3×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 1.0×FY 2017: 0.3×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 0.8×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 1.0×FY 2025: 0.3×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -704×
FY 2016: -1197×FY 2017: -460×FY 2018: -870×FY 2019: -39.5×FY 2020: -236×FY 2021: -227×FY 2022: -337×FY 2023: -398×FY 2024: -268×FY 2025: -704×
FY 2016 5y median -337× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31